These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 24421050)

  • 1. Protection of mice against Shiga toxin 2 (Stx2)-associated damage by maternal immunization with a Brucella lumazine synthase-Stx2 B subunit chimera.
    Mejias MP; Cabrera G; Fernández-Brando RJ; Baschkier A; Ghersi G; Abrey-Recalde MJ; Miliwebsky E; Meiss R; Goldbaum F; Zylberman V; Rivas M; Palermo MS
    Infect Immun; 2014 Apr; 82(4):1491-9. PubMed ID: 24421050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization with BLS-Stx2B chimera totally protects dams from early pregnancy loss induced by Shiga toxin type 2 (Stx2) and confers anti-Stx2 immunity to the offspring.
    Sacerdoti F; Mejías MP; Bruballa AC; Alvarez RS; Amaral MM; Palermo MS; Ibarra C
    Vaccine; 2016 Sep; 34(39):4732-4737. PubMed ID: 27527816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization with a chimera consisting of the B subunit of Shiga toxin type 2 and brucella lumazine synthase confers total protection against Shiga toxins in mice.
    Mejias MP; Ghersi G; Craig PO; Panek CA; Bentancor LV; Baschkier A; Goldbaum FA; Zylberman V; Palermo MS
    J Immunol; 2013 Sep; 191(5):2403-11. PubMed ID: 23918978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of a recombinant Intimin, EspB and Shiga toxin 2B vaccine in calves experimentally challenged with Escherichia coli O157:H7.
    Martorelli L; Garimano N; Fiorentino GA; Vilte DA; Garbaccio SG; Barth SA; Menge C; Ibarra C; Palermo MS; Cataldi A
    Vaccine; 2018 Jun; 36(27):3949-3959. PubMed ID: 29807709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune Response in Calves Vaccinated with Type Three Secretion System Antigens and Shiga Toxin 2B Subunit of Escherichia coli O157:H7.
    Martorelli L; Garbaccio S; Vilte DA; Albanese AA; Mejías MP; Palermo MS; Mercado EC; Ibarra CE; Cataldi AA
    PLoS One; 2017; 12(1):e0169422. PubMed ID: 28046078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter sequence of Shiga toxin 2 (Stx2) is recognized in vivo, leading to production of biologically active Stx2.
    Bentancor LV; Mejías MP; Pinto A; Bilen MF; Meiss R; Rodriguez-Galán MC; Baez N; Pedrotti LP; Goldstein J; Ghiringhelli PD; Palermo MS
    mBio; 2013 Oct; 4(5):e00501-13. PubMed ID: 24085779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salmonella enterica serovar Typhimurium vaccine strains expressing a nontoxic Shiga-like toxin 2 derivative induce partial protective immunity to the toxin expressed by enterohemorrhagic Escherichia coli.
    Rojas RL; Gomes PA; Bentancor LV; Sbrogio-Almeida ME; Costa SO; Massis LM; Ferreira RC; Palermo MS; Ferreira LC
    Clin Vaccine Immunol; 2010 Apr; 17(4):529-36. PubMed ID: 20147499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies anti-Shiga toxin 2 B subunit from chicken egg yolk: isolation, purification and neutralization efficacy.
    Parma YR; Chacana PA; Rogé A; Kahl A; Cangelosi A; Geoghegan P; Lucchesi PM; Fernández-Miyakawa ME
    Toxicon; 2011 Sep; 58(4):380-8. PubMed ID: 21803069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enterohemorrhagic Escherichia coli trivalent recombinant vaccine containing EspA, intimin and Stx2 induces strong humoral immune response and confers protection in mice.
    Gu J; Liu Y; Yu S; Wang H; Wang Q; Yi Y; Zhu F; Yu XJ; Zou Q; Mao X
    Microbes Infect; 2009 Sep; 11(10-11):835-41. PubMed ID: 19427397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Stx2-specific monoclonal antibodies prevent systemic complications of Escherichia coli O157:H7 infection.
    Mukherjee J; Chios K; Fishwild D; Hudson D; O'Donnell S; Rich SM; Donohue-Rolfe A; Tzipori S
    Infect Immun; 2002 Feb; 70(2):612-9. PubMed ID: 11796590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of camelid single chain antibodies against Shiga toxin type 2 (Stx2) with therapeutic potential against Hemolytic Uremic Syndrome (HUS).
    Mejías MP; Hiriart Y; Lauché C; Fernández-Brando RJ; Pardo R; Bruballa A; Ramos MV; Goldbaum FA; Palermo MS; Zylberman V
    Sci Rep; 2016 Apr; 6():24913. PubMed ID: 27118524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a bivalent food poisoning vaccine: augmented antigenicity of the C-terminus of Clostridium perfringens enterotoxin by fusion with the B subunit of Escherichia coli Shiga toxin 2.
    Hosomi K; Hinenoya A; Suzuki H; Nagatake T; Nishino T; Tojima Y; Hirata SI; Matsunaga A; Kondoh M; Yamasaki S; Kunisawa J
    Int Immunol; 2019 Feb; 31(2):91-100. PubMed ID: 30329068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A plant-based oral vaccine to protect against systemic intoxication by Shiga toxin type 2.
    Wen SX; Teel LD; Judge NA; O'Brien AD
    Proc Natl Acad Sci U S A; 2006 May; 103(18):7082-7. PubMed ID: 16641102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant Shiga toxin B-subunit-keyhole limpet hemocyanin conjugate vaccine protects mice from Shigatoxemia.
    Marcato P; Griener TP; Mulvey GL; Armstrong GD
    Infect Immun; 2005 Oct; 73(10):6523-9. PubMed ID: 16177326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of a novel Stx2B-Stx1B fusion protein in a mice model of Enterohemorrhagic Escherichia coli O157:H7 infection.
    Gao X; Cai K; Shi J; Liu H; Hou X; Tu W; Xiao L; Wang Q; Wang H
    Vaccine; 2009 Mar; 27(14):2070-6. PubMed ID: 19428832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization of pregnant cows with Shiga toxin-2 induces high levels of specific colostral antibodies and lactoferrin able to neutralize E. coli O157:H7 pathogenicity.
    Albanese A; Sacerdoti F; Seyahian EA; Amaral MM; Fiorentino G; Fernandez Brando R; Vilte DA; Mercado EC; Palermo MS; Cataldi A; Zotta E; Ibarra C
    Vaccine; 2018 Mar; 36(13):1728-1735. PubMed ID: 29483033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shiga toxin 2-specific but not shiga toxin 1-specific human monoclonal antibody protects piglets challenged with enterohemorrhagic Escherichia coli producing shiga toxin 1 and shiga toxin 2.
    Jeong KI; Tzipori S; Sheoran AS
    J Infect Dis; 2010 Apr; 201(7):1081-3. PubMed ID: 20196656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection against Shiga toxin-producing Escherichia coli infection by transcutaneous immunization with Shiga toxin subunit B.
    Zhu C; Yu J; Yang Z; Davis K; Rios H; Wang B; Glenn G; Boedeker EC
    Clin Vaccine Immunol; 2008 Feb; 15(2):359-66. PubMed ID: 18003816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection of monkeys against Shiga toxin induced by Shiga toxin-liposome conjugates.
    Suzaki Y; Ami Y; Nagata N; Naito S; Kato H; Taneichi M; Takahashi M; Komiya T; Satoh S; Gondaira F; Sugiyama J; Nakano Y; Mori M; Komuro K; Uchida T
    Int Arch Allergy Immunol; 2002 Apr; 127(4):294-8. PubMed ID: 12021548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Shiga toxin 2 antibodies in enterohemorrhagic Escherichia coli O104:H4 infected patients may predict hemolytic uremic syndrome.
    Dammermann W; Mihajlov V; Middendorf B; Mellmann A; Karch H; Lüth S; Ullrich S
    J Gastroenterol Hepatol; 2018 Jul; 33(7):1353-1356. PubMed ID: 29280264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.